CN Patent

CN111132700A — 双模放射性示踪剂与治疗剂

Assigned to Isar River Right Bank Hospital Technical University Of Munich · Expires 2020-05-08 · 6y expired

What this patent protects

本发明涉及配体‑SIFA‑螯合剂偶联物，其在单个分子中包含三个独立部分：(a)一或多种能够与疾病相关靶分子结合的配体，(b)氟化硅受体(SIFA)部分，其包含硅原子与氟原子之间的共价键，以及(c)一或多种螯合基团，任选地含有螯合的非放射性或放射性阳离子。

USPTO Abstract

本发明涉及配体‑SIFA‑螯合剂偶联物，其在单个分子中包含三个独立部分：(a)一或多种能够与疾病相关靶分子结合的配体，(b)氟化硅受体(SIFA)部分，其包含硅原子与氟原子之间的共价键，以及(c)一或多种螯合基团，任选地含有螯合的非放射性或放射性阳离子。

Drugs covered by this patent

Patent Metadata

Patent number
CN111132700A
Jurisdiction
CN
Classification
—
Expires
2020-05-08
Drug substance claim
No
Drug product claim
No
Assignee
Isar River Right Bank Hospital Technical University Of Munich
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.